These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 26992879)

  • 21. An RCT of adherence therapy for people with schizophrenia in Chiang Mai, Thailand.
    Maneesakorn S; Robson D; Gournay K; Gray R
    J Clin Nurs; 2007 Jul; 16(7):1302-12. PubMed ID: 17584349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improving Adherence in Hospitalized Patients Diagnosed With Schizophrenia: An Integrative One-on-One Intervention.
    Dahan S; Behrbalk P; Stolovy T; Greenberger C
    Arch Psychiatr Nurs; 2016 Dec; 30(6):660-665. PubMed ID: 27888956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in medication adherence, satisfaction and clinical symptoms in schizophrenic outpatients taking different antipsychotic regimens.
    Sweileh WM; Ihbesheh MS; Jarar IS; Sawalha AF; Abu Taha AS; Zyoud SH; Morisky DE
    Curr Drug Saf; 2011 Nov; 6(5):285-90. PubMed ID: 22424535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Drug compliance and health locus of control in schizophrenia].
    Combes C; Feral F
    Encephale; 2011 May; 37 Suppl 1():S11-8. PubMed ID: 21600328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novelty seeking and medication adherence in patients with schizophrenia.
    Aukst Margetić B; Jakovljević M; Ivanec D; Tošić G; Margetić B
    Psychiatry Res; 2011 Mar; 186(1):141-3. PubMed ID: 20630601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adherence therapy versus routine psychiatric care for people with schizophrenia spectrum disorders: a randomised controlled trial.
    Chien WT; Mui J; Gray R; Cheung E
    BMC Psychiatry; 2016 Feb; 16():42. PubMed ID: 26911397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of long-acting injectable risperidone versus oral antipsychotics in the treatment of recent-onset schizophrenia: a case-control study.
    Barrio P; Batalla A; Castellví P; Hidalgo D; García M; Ortiz A; Grande I; Pons A; Parellada E
    Int Clin Psychopharmacol; 2013 Jul; 28(4):164-70. PubMed ID: 23587986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A short message service (SMS)-based strategy for enhancing adherence to antipsychotic medication in schizophrenia.
    Montes JM; Medina E; Gomez-Beneyto M; Maurino J
    Psychiatry Res; 2012 Dec; 200(2-3):89-95. PubMed ID: 22901437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measuring adherence to medication in schizophrenia: the relationship between attitudes toward drug therapy and plasma levels of new-generation antipsychotics.
    Yalcin-Siedentopf N; Wartelsteiner F; Kaufmann A; Biedermann F; Edlinger M; Kemmler G; Rettenbacher MA; Widschwendter CG; Zernig G; Fleischhacker WW; Hofer A
    Int J Neuropsychopharmacol; 2014 Dec; 18(5):. PubMed ID: 25522423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparing cognitive functions in medication adherent and non-adherent patients with schizophrenia.
    El-Missiry A; Elbatrawy A; El Missiry M; Moneim DA; Ali R; Essawy H
    J Psychiatr Res; 2015 Nov; 70():106-12. PubMed ID: 26424429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of subjective treatment satisfaction with antipsychotics in schizophrenia patients.
    Fujikawa M; Togo T; Yoshimi A; Fujita J; Nomoto M; Kamijo A; Amagai T; Uchikado H; Katsuse O; Hosojima H; Sakura Y; Furusho R; Suda A; Yamaguchi T; Hori T; Kamada A; Kondo T; Ito M; Odawara T; Hirayasu Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):755-60. PubMed ID: 18226436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors associated with medication adherence among patients with schizophrenia in Mekelle, Northern Ethiopia.
    Eticha T; Teklu A; Ali D; Solomon G; Alemayehu A
    PLoS One; 2015; 10(3):e0120560. PubMed ID: 25816353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of the Nursing Psychoeducation Program on the Acceptance of Medication and Condition-Specific Knowledge of Patients with Schizophrenia.
    Matsuda M; Kohno A
    Arch Psychiatr Nurs; 2016 Oct; 30(5):581-6. PubMed ID: 27654241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder.
    Byerly MJ; Nakonezny PA; Rush AJ
    Schizophr Res; 2008 Mar; 100(1-3):60-9. PubMed ID: 18255269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Negative impact of self-stigmatization on attitude toward medication adherence in patients with psychosis.
    Uhlmann C; Kaehler J; Harris MS; Unser J; Arolt V; Lencer R
    J Psychiatr Pract; 2014 Sep; 20(5):405-10. PubMed ID: 25226204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Twelve months of electronic monitoring (MEMS®) in the Swedish COAST-study: a comparison of methods for the measurement of adherence in schizophrenia.
    Brain C; Sameby B; Allerby K; Lindström E; Eberhard J; Burns T; Waern M
    Eur Neuropsychopharmacol; 2014 Feb; 24(2):215-22. PubMed ID: 24359935
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized controlled trial of long-acting injectable risperidone vs continuation on oral atypical antipsychotics for first-episode schizophrenia patients: initial adherence outcome.
    Weiden PJ; Schooler NR; Weedon JC; Elmouchtari A; Sunakawa A; Goldfinger SM
    J Clin Psychiatry; 2009 Oct; 70(10):1397-406. PubMed ID: 19906343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early perception of medication benefit predicts subsequent antipsychotic response in schizophrenia: "the consumer has a point" revisited.
    Ascher-Svanum H; Weiden P; Nyhuis AW; Faries DE; Stauffer V; Kollack-Walker S; Kinon BJ
    Clin Schizophr Relat Psychoses; 2014 Jul; 8(2):84-90, 90A. PubMed ID: 23446198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subjective reasons for adherence to psychotropic medication and associated factors among older adults with schizophrenia.
    Sapra M; Vahia IV; Reyes PN; Ramirez P; Cohen CI
    Schizophr Res; 2008 Dec; 106(2-3):348-55. PubMed ID: 18851906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adherence styles of schizophrenia patients identified by a latent class analysis of the Medication Adherence Rating Scale (MARS): a six-month follow-up study.
    Jaeger S; Pfiffner C; Weiser P; Kilian R; Becker T; Längle G; Eschweiler GW; Croissant D; Schepp W; Steinert T
    Psychiatry Res; 2012 Dec; 200(2-3):83-8. PubMed ID: 22534500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.